Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance
- PMID: 19095724
- PMCID: PMC2662849
- DOI: 10.1373/clinchem.2008.119206
Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance
Conflict of interest statement
Comment on
-
Adeno-associated virus-mediated human C-reactive protein gene delivery causes endothelial dysfunction and hypertension in rats.Clin Chem. 2009 Feb;55(2):274-84. doi: 10.1373/clinchem.2008.115857. Epub 2008 Dec 4. Clin Chem. 2009. PMID: 19056836 Free PMC article.
References
-
- Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913–9. - PubMed
-
- Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-Reactive protein decrease eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002;106:1439–41. - PubMed
-
- Dasu MR, Devaraj S, Du Clos TW, Jialal I. The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells. J Lipid Res. 2007;48:509–12. - PubMed
-
- Mineo C, Gormley AK, Yuhanna IS, Osborne-Lawrence S, Gibson LL, Hahner L, et al. FcγRIIB mediates C-reactive protein inhibition of endothelial NO synthase. Circ Res. 2005;97:1124–31. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
